BioSpace News Archive

World leader in breast cancer screening celebrates start of Breast Cancer Awareness Month, releases new survey results on breast density

TherapeuticsMD, Inc. today announced that the Company has entered into discussions with the U.S. Food and Drug Administration (FDA) regarding the proposed label for TX-001HR, the Company’s investigational bio-identical hormone therapy combination of estradiol and progesterone in a single, oral softgel for the treatment of moderate-to-severe vasomotor symptoms due to menopause.

Verastem, Inc. today announced that the Company will present at the following upcoming investor conferences

Bill reforms tax rules that currently penalize investment in job creation, innovation

Consumers should be able to know at a quick glance what type of product they’re purchasing for themselves and their families. Implementing clear and transparent food labels and claims is an issue I’ve made a high priority.

Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Alnylam Pharmaceuticals, Inc.

Top Scientists to Reveal Latest in Arthritis Prevention and Treatment at ROAR 2018

A prospective longitudinal natural history registry designed to provide long-term data evaluating people living with cystinosis was launched today at a meeting of The North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) in Chicago, Ill.

ADEL ABDULLAH PRESIDENT & AARON HARGRAVE VICE PRESIDENT

Evoke (www.evokegroup.com), part of Huntsworth plc (HNT: LSE), today announces the acquisition of New Jersey-based Navience Healthcare Solutions.